Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

PubWeight™: 11.97‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 10902785)

Published in J Clin Endocrinol Metab on July 01, 2000

Authors

A Katz1, S S Nambi, K Mather, A D Baron, D A Follmann, G Sullivan, M J Quon

Author Affiliations

1: Hypertension-Endocrine Branch and Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Associated clinical trials:

Safety and Efficacy of Long Limb Roux-en Y Reconstruction (LoLiRoRe) | NCT01373346

Vitamin D and Glucose Metabolism in Pediatrics | NCT01386736

Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes | NCT02754739

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain | NCT01844700

Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome (PRIME) | NCT03031821

Articles citing this

(truncated to the top 100)

Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med (2004) 11.17

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med (2008) 4.85

Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes (2007) 3.23

Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes (2014) 3.21

Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) (2008) 3.18

Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care (2009) 3.03

Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child (2005) 2.52

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45

Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes (2008) 2.38

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology (2008) 2.33

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut (2007) 2.23

Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension (2012) 2.23

Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci (2006) 2.23

Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol (2008) 2.22

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol (2010) 2.18

Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr (2010) 1.99

Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. Sleep (2007) 1.88

Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res (2013) 1.81

Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr (2008) 1.78

Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp Biol Med (Maywood) (2008) 1.77

Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J (2009) 1.64

Obesity, insulin resistance, and pregnancy outcome. Reproduction (2010) 1.64

Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res (2009) 1.60

Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr (2011) 1.59

Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care (2012) 1.58

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res (2002) 1.57

The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. J Gastroenterol (2010) 1.57

Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care (2008) 1.57

Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics (2012) 1.55

The impact and safety of preoperative oral or intravenous carbohydrate administration versus fasting in colorectal surgery--a randomized controlled trial. Wien Klin Wochenschr (2010) 1.54

A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss. Am J Physiol Endocrinol Metab (2009) 1.54

Acute testosterone deprivation reduces insulin sensitivity in men. Clin Endocrinol (Oxf) (2012) 1.53

Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol (2010) 1.52

A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am J Physiol Endocrinol Metab (2010) 1.49

Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med (2010) 1.48

Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr (2010) 1.47

Surrogate markers of insulin resistance: A review. World J Diabetes (2010) 1.46

Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs. Diabetes (2013) 1.45

Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomized controlled trial. Evid Based Complement Alternat Med (2011) 1.44

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care (2009) 1.41

Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab (2009) 1.40

Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39

Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci (2006) 1.38

Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr (2009) 1.38

Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci (2003) 1.37

Curcumin extract for prevention of type 2 diabetes. Diabetes Care (2012) 1.36

Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care (2012) 1.35

Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol Pharmacol (2009) 1.32

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol (2010) 1.32

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol (2012) 1.30

The effects of high walnut and cashew nut diets on the antioxidant status of subjects with metabolic syndrome. Eur J Nutr (2007) 1.29

Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. Atherosclerosis (2008) 1.28

Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab (2007) 1.23

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol (2013) 1.22

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. Diabetes Care (2008) 1.22

Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2008) 1.22

Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol (2011) 1.22

Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab (2011) 1.21

OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity (Silver Spring) (2008) 1.19

Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions. Sleep (2015) 1.19

Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2009) 1.19

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.17

Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab (2009) 1.16

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol (2010) 1.16

Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr (2003) 1.15

Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.11

Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res (2009) 1.10

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09

A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.09

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) (2006) 1.09

Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis (2009) 1.08

Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort. J Acquir Immune Defic Syndr (2013) 1.08

Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol (2008) 1.07

Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab (2008) 1.07

Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin Nutr (2011) 1.06

Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol (2011) 1.06

Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis (2010) 1.05

Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons. Cardiovasc Diabetol (2009) 1.05

A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr (2013) 1.05

Ethnicity and weight status affect the accuracy of proxy indices of insulin sensitivity. Obesity (Silver Spring) (2008) 1.05

Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging (2013) 1.05

Metabolic effects of chronic cannabis smoking. Diabetes Care (2013) 1.04

Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord (2010) 1.04

Chemotherapy for testicular cancer induces acute alterations in diastolic heart function. Br J Cancer (2013) 1.04

Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol (2010) 1.04

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J Clin Endocrinol Metab (2009) 1.03

GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology (2013) 1.03

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry (2013) 1.03

Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res (2011) 1.02

Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) (2011) 1.02

Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose. J Clin Endocrinol Metab (2009) 1.02

Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes (2011) 1.02

Measurement of insulin resistance in chronic kidney disease. Curr Opin Nephrol Hypertens (2011) 1.02

Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res (2013) 1.02

Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes. J Pediatr (2012) 1.01

Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr (2008) 1.01

Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents. J Bone Miner Metab (2009) 1.01

Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy. Int J Diabetes Dev Ctries (2008) 1.01

Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol Med (2009) 1.00

Alternanthera sessilis Red Ethyl Acetate Fraction Exhibits Antidiabetic Potential on Obese Type 2 Diabetic Rats. Evid Based Complement Alternat Med (2013) 1.00

Articles by these authors

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest (1990) 3.74

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest (1996) 2.82

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation (2000) 2.59

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest (1997) 2.57

Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol (1997) 2.51

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42

Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action. J Biol Chem (1993) 2.41

Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation (1997) 2.26

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes (1992) 2.16

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care (2001) 1.99

Vascular function, insulin resistance and fatty acids. Diabetologia (2002) 1.97

Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr (1995) 1.86

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82

A national survey into the peri-operative anaesthetic management of patients presenting for surgical correction of a fractured neck of femur. Anaesthesia (2008) 1.80

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem (1999) 1.77

Physical dependence on zopiclone: case reports. BMJ (1998) 1.76

Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest (1996) 1.72

Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab (2001) 1.71

Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes (2000) 1.71

Genotype X environment interactions. II. Some genetical considerations. Heredity (Edinb) (1975) 1.64

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal. J Urol (1997) 1.63

Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension (1998) 1.61

The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med (1992) 1.59

Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes (2000) 1.59

Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology (2001) 1.56

Mutations in the insulin receptor gene. Endocr Rev (1992) 1.55

Protecting third parties: a decade after Tarasoff. Am J Psychiatry (1987) 1.54

Utilization of mental health and substance abuse services among homeless adults in Los Angeles. Med Care (1999) 1.54

Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest (2000) 1.51

Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem (2000) 1.50

Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am J Physiol (1991) 1.50

Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem J (2001) 1.49

Effect on ICU mortality of a full-time critical care specialist. Chest (1989) 1.49

Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation (1999) 1.48

Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care (1999) 1.46

Prophylaxis and management of hamstring muscle injuries in intercollegiate football players. Am J Sports Med (1984) 1.42

Myopathy of internal anal sphincter with polyglucosan inclusions. J Pathol (1990) 1.39

Modeling repeated count data subject to informative dropout. Biometrics (2000) 1.38

Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry (1998) 1.36

Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation (2001) 1.34

Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation (2000) 1.32

Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest (1985) 1.32

Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol (1999) 1.30

Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology (1998) 1.30

The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem (1995) 1.29

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes (1987) 1.27

Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol (2012) 1.23

Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol (2001) 1.21

Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition. Kidney Int (2001) 1.20

Complementary and duplicate gene interactions in biometrical genetics. Heredity (Edinb) (1967) 1.19

Impaired glucose tolerance. Why is it not a disease? Diabetes Care (1999) 1.18

Insulin receptor binding kinetics: modeling and simulation studies. J Theor Biol (2000) 1.17

Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab (2000) 1.16

Value of postprocedural chest radiographs in the adult intensive care unit. Crit Care Med (1992) 1.16

Phosphorylation of critical serine residues in Gem separates cytoskeletal reorganization from down-regulation of calcium channel activity. Mol Cell Biol (2004) 1.16

Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care (1997) 1.15

Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab (2001) 1.14

Protein kinase C-zeta and phosphoinositide-dependent protein kinase-1 are required for insulin-induced activation of ERK in rat adipocytes. J Biol Chem (1999) 1.13

Office hypertension in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.12

Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol Endocrinol (2001) 1.12

Insulin-mediated vasodilation: why one's physiology could be the other's pharmacology. Diabetologia (1999) 1.10

Identification of alpha- and beta-amanitin by thin-layer chromatography. J Pharm Sci (1965) 1.09

Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab (2013) 1.09

Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08

Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal (1999) 1.07

Glucose activates protein kinase C-zeta /lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D: a novel mechanism for activating glucose transporter translocation. J Biol Chem (2001) 1.06

Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta. Mol Endocrinol (1999) 1.05

Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care (2004) 1.05

Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes. An apparent requirement for activation of Glut4 translocation and glucose transport. J Biol Chem (1999) 1.04

The accuracy of medical record documentation in schizophrenia. J Behav Health Serv Res (2001) 1.03

Characteristics of patients with schizophrenia who do not believe they are mentally ill. J Nerv Ment Dis (2001) 1.02

A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol (2011) 1.01

Genotype--environment interaction. III. Interactions in Drosophila melanogaster. Proc R Soc Lond B Biol Sci (1975) 1.01

Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells. J Immunol (2000) 1.01

Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling. Am J Physiol (1998) 0.99

Postprandial lipaemia, oxidative stress and endothelial function: a review. Int J Clin Pract (2010) 0.99

Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer. Ann Oncol (2008) 0.97

Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action. J Biol Chem (1992) 0.97

Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes (1990) 0.96

Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse. Metabolism (1999) 0.96

Quality-of-care research in mental health: responding to the challenge. Inquiry (1988) 0.96

Non-allelic interaction in continuous variation of randomly breeding populations. Heredity (Edinb) (1974) 0.94

Functioning and disability levels in primary care out-patients with one or more anxiety disorders. Psychol Med (2010) 0.94

Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter. J Biol Chem (2000) 0.93

A UK consensus on the administration of aripiprazole for the treatment of mania. J Psychopharmacol (2008) 0.92

Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol (1992) 0.92

Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol (1997) 0.92

Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes (1999) 0.91

Microdissection: a novel method for the study of intracellular inclusion bodies. J Pathol (1990) 0.91

Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells. Mol Endocrinol (1999) 0.90

Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab (1995) 0.90

The rapid infusion system: a superior method for the resuscitation of hypovolemic trauma patients. Resuscitation (1991) 0.90

Migraine precipitated by head trauma in athletes. Am J Sports Med (1980) 0.90

Insulin stimulates increased catalytic activity of phosphoinositide-dependent kinase-1 by a phosphorylation-dependent mechanism. Biochemistry (2001) 0.90

A well-being programme in severe mental illness. Baseline findings in a UK cohort. Int J Clin Pract (2007) 0.90